Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Associations of severe COVID-19 with polypharmacy in the REACT-SCOT case-control study

View ORCID ProfilePaul M McKeigue, Sharon Kennedy, Amanda Weir, Jen Bishop, View ORCID ProfileStuart J McGurnaghan, David McAllister, Chris Robertson, Rachael Wood, Nazir Lone, Janet Murray, View ORCID ProfileThomas M Caparrotta, Alison Smith-Palmer, David Goldberg, Jim McMenamin, Colin Ramsay, Bruce Guthrie, Sharon Hutchinson, View ORCID ProfileHelen M Colhoun On behalf of Public Health Scotland COVID-19 Health Protection Study Group.
doi: https://doi.org/10.1101/2020.07.23.20160747
Paul M McKeigue
1Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
3Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Roles: Professor of Genetic Epidemiology and Statistical Genetics.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul M McKeigue
Sharon Kennedy
7NHS Information Services Division (Public Health Scotland), Gyle Square, 1 South Gyle Crescent, Edinburgh, EH12 9EB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Weir
3Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jen Bishop
3Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart J McGurnaghan
2Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XUC, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stuart J McGurnaghan
David McAllister
4Institute of Health and Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ
3Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Roles: Wellcome Trust Intermediate Clinical Fellow and Beit Fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Robertson
5Department of Mathematics and Statistics, University of Strathclyde, 16 Richmond Street, Glasgow G1 1XQ
3Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Roles: Professor of Public Health Epidemiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachael Wood
7NHS Information Services Division (Public Health Scotland), Gyle Square, 1 South Gyle Crescent, Edinburgh, EH12 9EB
Roles: Consultant in Maternal and Child Health.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nazir Lone
1Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
Roles: Clinical Senior Lecturer in Critical Care
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet Murray
3Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas M Caparrotta
2Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XUC, Scotland
Roles: Sir George Alberti Doctoral Fellow in Pharmacoepidemiology.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas M Caparrotta
Alison Smith-Palmer
3Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Goldberg
3Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jim McMenamin
3Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colin Ramsay
3Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Roles: Professor of Public Health Epidemiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Guthrie
1Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon Hutchinson
6School of Health and Life Sciences, Glasgow Caledonian University
3Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Roles: Professor of Epidemiology and Population Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen M Colhoun
2Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XUC, Scotland
3Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Roles: Axa Chair in Medical Informatics and Epidemiology.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helen M Colhoun
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives To investigate the relation of severe COVID-19 to prior drug prescribing.

Design Matched case-control study (REACT-SCOT) based on record linkage to hospital discharges since June 2015 and dispensed prescriptions issued in primary care during the last 240 days.

Setting Scottish population.

Main outcome measure Severe COVID-19, defined by entry to critical care or fatal outcome.

Participants All 4272 cases of severe COVID-19 in Scotland since the start of the epidemic, with 36948 controls matched for age, sex and primary care practice.

Results Severe COVID-19 was strongly associated with the number of non-cardiovascular drug classes dispensed. This association was strongest in those not resident in care homes, in whom the rate ratio (95% CI) associated with dispensing of 12 or more drug classes versus none was 10.8 (8.7, 13.2), and was not accounted for by treatment of conditions designated as conferring increased risk. Of 17 drug classes postulated at the start of the epidemic to be “medications compromising COVID”, all were associated with increased risk of severe COVID-19. The largest effect was for antipsychotic agents: rate ratio 4.14 (3.39, 5.07). Other drug classes with large effects included proton pump inhibitors (rate rato 2.19 (1.70, 2.80) for >= 2 defined daily doses/day), opioids (3.62 (2.65, 4.94) for >= 50 mg morphine equivalent/day) and gabapentinoids. These associations persisted after adjusting for covariates, and were stronger with recent than with non-recent exposure.

Conclusions Severe COVID-19 is associated with polypharmacy and with drugs that cause sedation, respiratory depression or dyskinesia, have anticholinergic effects or affect the gastrointestinal system. These associations are not easily explained by co-morbidity. Although the evidence for causality is not conclusive, these results support existing guidance on reducing overprescribing of these drug classes and limiting inappropriate polypharmacy as a potential means of reducing COVID-19 risk.

Registration ENCEPP number EUPAS35558

What is already known on this topic Two previous studies have examined the relationship of severe COVID-19 to drugs for the cardiovascular system. This is the first systematic study of the relationship of severe COVID-19 to prior drug prescribing.

What this study adds Severe COVID-19 is associated with polypharmacy and with drugs that cause sedation, respiratory depression or dyskinesia, have anticholinergic effects or affect the gastrointestinal system. These associations are not easily explained by co-morbidity. These results support earlier warnings that these drug classes that these drugs might increase susceptibility to COVID-19, and reinforce existing guidance on reducing overprescribing of these drug classes.

Competing Interest Statement

HC receives research support and honoraria and is a member of advisory panels or speaker bureaus for Sanofi Aventis, Regeneron, Novartis, Novo-Nordisk and Eli Lilly. HC receives or has recently received non-binding research support from AstraZeneca and Novo-Nordisk. SH received honoraria from Gilead.

Clinical Protocols

http://www.encepp.eu/encepp/viewResource.htm?id=35559

Funding Statement

This study was not supported by any external funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Public Benefit and Privacy Panel for Health and Social Care, Scotland

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Applications for access to the data may be made to the Public Benefit and Privacy Panel for Health and Social Care, Scotland

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 27, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Associations of severe COVID-19 with polypharmacy in the REACT-SCOT case-control study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Associations of severe COVID-19 with polypharmacy in the REACT-SCOT case-control study
Paul M McKeigue, Sharon Kennedy, Amanda Weir, Jen Bishop, Stuart J McGurnaghan, David McAllister, Chris Robertson, Rachael Wood, Nazir Lone, Janet Murray, Thomas M Caparrotta, Alison Smith-Palmer, David Goldberg, Jim McMenamin, Colin Ramsay, Bruce Guthrie, Sharon Hutchinson, Helen M Colhoun
medRxiv 2020.07.23.20160747; doi: https://doi.org/10.1101/2020.07.23.20160747
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Associations of severe COVID-19 with polypharmacy in the REACT-SCOT case-control study
Paul M McKeigue, Sharon Kennedy, Amanda Weir, Jen Bishop, Stuart J McGurnaghan, David McAllister, Chris Robertson, Rachael Wood, Nazir Lone, Janet Murray, Thomas M Caparrotta, Alison Smith-Palmer, David Goldberg, Jim McMenamin, Colin Ramsay, Bruce Guthrie, Sharon Hutchinson, Helen M Colhoun
medRxiv 2020.07.23.20160747; doi: https://doi.org/10.1101/2020.07.23.20160747

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1100)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9782)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2318)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (506)
  • Infectious Diseases (except HIV/AIDS) (11656)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (239)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2148)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (365)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2188)
  • Public and Global Health (4673)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)